japans takeda to buy us cancer drug maker ariad for 5 2bn

Japan's Takeda to buy US cancer drug maker Ariad for $5.2bn

Company Himanshu Gill - Jan 10, 2017

Japan’s Takeda Pharmaceutical Co said that it will buy US-based cancer drug maker Ariad Pharmaceuticals for $5.20 billion.

australian court increases fine on nurofen for misleading customers

Australian court increases fine on Nurofen for misleading customers

Company Himanshu Gill - Dec 16, 2016

The UK based manufacturers of Nurofen have been fined with $4.4 million (A$ 6 million) by an Australian court for misleading consumers with its specific pain relief range.

Total Records (2 )